MARKETS

Micron’s stock recovery highlights improved long-term earnings potential in the memory sector, driven by new supply agreements.

Eli Lilly’s stock rises after a successful late-stage trial of its next-generation weight-loss drug, impressing analysts and investors alike.

Exploring the complexities of friendship and trust in finance through a personal story of betrayal and the implications for everyday relationships.

Morgan Stanley’s strategist discusses tech’s pullback as a healthy reset for the bull market, supported by improving earnings and economic conditions.

Investors are moving away from tech, favoring health insurers, banks, and retailers in a significant market shift. What does this mean for you?

Despite rising oil prices, S&P 500 companies report stable profit outlooks. Explore the implications for investors and everyday consumers.

Residents of a luxury retirement community are concerned as financial troubles threaten their investments. What does this mean for their future?

Learn how to withdraw from your 401(k) without increasing Medicare premiums and manage your finances effectively.

Robo-advisers excel at managing portfolios but struggle with AI-generated stock picks, impacting their profitability and market performance.

Explore new weight-loss therapies that aim to outperform GLP-1 options like Zepbound and Wegovy, offering hope for those struggling with side effects.